» Articles » PMID: 25455989

Assessment of Empirical Antibiotic Therapy Optimisation in Six Hospitals: an Observational Cohort Study

Abstract

Background: Modification of empirical antimicrobials when warranted by culture results or clinical signs is recommended to control antimicrobial overuse and resistance. We aimed to assess the frequency with which patients were started on empirical antimicrobials, characteristics of the empirical regimen and the clinical characteristics of patients at the time of starting antimicrobials, patterns of changes to empirical therapy at different timepoints, and modifiable factors associated with changes to the initial empirical regimen in the first 5 days of therapy.

Methods: We did a chart review of adult inpatients receiving one or more antimicrobials in six US hospitals on 4 days during 2009 and 2010. Our primary outcome was the modification of antimicrobial regimen on or before the 5th day of empirical therapy, analysed as a three-category variable. Bivariate analyses were used to establish demographic and clinical variables associated with the outcome. Variables with p values below 0·1 were included in a multivariable generalised linear latent and mixed model with multinomial logit link to adjust for clustering within hospitals and accommodate a non-binary outcome variable.

Findings: Across the six study sites, 4119 (60%) of 6812 inpatients received antimicrobials. Of 1200 randomly selected patients with active antimicrobials, 730 (61%) met inclusion criteria. At the start of therapy, 220 (30%) patients were afebrile and had normal white blood cell counts. Appropriate cultures were collected from 432 (59%) patients, and 250 (58%) were negative. By the 5th day of therapy, 12·5% of empirical antimicrobials were escalated, 21·5% were narrowed or discontinued, and 66·4% were unchanged. Narrowing or discontinuation was more likely when cultures were collected at the start of therapy (adjusted OR 1·68, 95% CI 1·05-2·70) and no infection was noted on an initial radiological study (1·76, 1·11-2·79). Escalation was associated with multiple infection sites (2·54, 1·34-4·83) and a positive culture (1·99, 1·20-3·29).

Interpretation: Broad-spectrum empirical therapy is common, even when clinical signs of infection are absent. Fewer than one in three inpatients have their regimens narrowed within 5 days of starting empirical antimicrobials. Improved diagnostic methods and continued education are needed to guide discontinuation of antimicrobials.

Funding: US Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion; Robert Wood Johnson Foundation; US Department of Veterans Administration; US Department of Homeland Security.

Citing Articles

Application of the Sepsis-3 criteria to describe sepsis epidemiology in the Amsterdam UMCdb intensive care dataset.

Williams C, Edinburgh T, Elbers P, Thoral P, Ercole A PLoS One. 2024; 19(6):e0304133.

PMID: 38905261 PMC: 11192388. DOI: 10.1371/journal.pone.0304133.


Antibiotic Guideline Adherence at the Emergency Department: A Descriptive Study from a Country with a Restrictive Antibiotic Policy.

Cartuliares M, Sogaard S, Rosenvinge F, Mogensen C, Hertz M, Skjot-Arkil H Antibiotics (Basel). 2023; 12(12).

PMID: 38136712 PMC: 10740443. DOI: 10.3390/antibiotics12121680.


Evaluation of point-of-care multiplex polymerase chain reaction in guiding antibiotic treatment of patients acutely admitted with suspected community-acquired pneumonia in Denmark: A multicentre randomised controlled trial.

Cartuliares M, Rosenvinge F, Mogensen C, Skovsted T, Andersen S, Ostergaard C PLoS Med. 2023; 20(11):e1004314.

PMID: 38015833 PMC: 10684013. DOI: 10.1371/journal.pmed.1004314.


Applications of Lab on a Chip in Antimicrobial Susceptibility of : A Systematic Review.

Ardila C, Zuluaga-Gomez M, Vivares-Builes A Medicina (Kaunas). 2023; 59(10).

PMID: 37893437 PMC: 10608121. DOI: 10.3390/medicina59101719.


Appropriateness of Empirical Antibiotic Therapy in Hospitalized Patients with Bacterial Infection: A Retrospective Cohort Study.

Luo Y, Guo Z, Li Y, Ouyang H, Huang S, Chen Y Infect Drug Resist. 2023; 16:4555-4568.

PMID: 37465180 PMC: 10350404. DOI: 10.2147/IDR.S402172.


References
1.
Olofsson S, Cars O . Optimizing drug exposure to minimize selection of antibiotic resistance. Clin Infect Dis. 2007; 45 Suppl 2:S129-36. DOI: 10.1086/519256. View

2.
Alvarez-Lerma F, Alvarez B, Luque P, Ruiz F, Dominguez-Roldan J, Quintana E . Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study. Crit Care. 2006; 10(3):R78. PMC: 1550932. DOI: 10.1186/cc4919. View

3.
Goossens H, Ferech M, Vander Stichele R, Elseviers M . Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365(9459):579-87. DOI: 10.1016/S0140-6736(05)17907-0. View

4.
Johannsson B, Johnson S, Ernst E, Beekmann S, Herwaldt L, Diekema D . Antimicrobial therapy for bloodstream infection due to methicillin-susceptible Staphylococcus aureus in an era of increasing methicillin resistance: opportunities for antimicrobial stewardship. Ann Pharmacother. 2012; 46(6):904-5. DOI: 10.1345/aph.1Q406. View

5.
Soni N, Samson D, Galaydick J, Vats V, Huang E, Aronson N . Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis. J Hosp Med. 2013; 8(9):530-40. DOI: 10.1002/jhm.2067. View